114 related articles for article (PubMed ID: 2627411)
1. Influence of the size of the area of treatment on percutaneous absorption of estradiol in the rat.
Chanez JF; de Lignières B; Marty JP; Wepierre J
Skin Pharmacol; 1989; 2(1):15-21. PubMed ID: 2627411
[TBL] [Abstract][Full Text] [Related]
2. In vivo percutaneous absorption of acetochlor in the rhesus monkey: dose-response and exposure risk assessment.
Wester RC; Melendres JL; Maibach HI
Food Chem Toxicol; 1996 Oct; 34(10):979-83. PubMed ID: 9012773
[TBL] [Abstract][Full Text] [Related]
3. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs.
Carver MP; Riviere JE
Fundam Appl Toxicol; 1989 Nov; 13(4):714-22. PubMed ID: 2620792
[TBL] [Abstract][Full Text] [Related]
5. Experimental methods for determining permethrin dermal absorption.
Reifenrath WG; Ross JH; Driver JH
J Toxicol Environ Health A; 2011; 74(5):325-35. PubMed ID: 21240732
[TBL] [Abstract][Full Text] [Related]
6. Glyphosate skin binding, absorption, residual tissue distribution, and skin decontamination.
Wester RC; Melendres J; Sarason R; McMaster J; Maibach HI
Fundam Appl Toxicol; 1991 May; 16(4):725-32. PubMed ID: 1884912
[TBL] [Abstract][Full Text] [Related]
7. In vivo human transfer of topical bioactive drug between individuals: estradiol.
Wester RC; Hui X; Maibach HI
J Invest Dermatol; 2006 Oct; 126(10):2190-3. PubMed ID: 16778801
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé) solution in healthy volunteers.
Everett DW; Franz TJ; Chando TJ; Gale PJ; Lehman PA; Schwarzel EH; Parab PV; D'Arienzo CJ; Kripalani KJ
Biopharm Drug Dispos; 1999 Sep; 20(6):301-8. PubMed ID: 10701701
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous absorption and tissue distribution of [3H]diacetoxyscirpenol (anguidine) in rats and mice.
Wang JS; Busby WF; Wogan GN
Toxicol Appl Pharmacol; 1996 Oct; 140(2):264-73. PubMed ID: 8887442
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous absorption and excretion of alachlor in rhesus monkeys.
Kronenberg JM; Fuhremann TW; Johnson DE
Fundam Appl Toxicol; 1988 May; 10(4):664-71. PubMed ID: 3396793
[TBL] [Abstract][Full Text] [Related]
11. Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.
Khetarpal VK; Markham PM; Ziemniak JA
Drug Metab Dispos; 1994; 22(2):216-23. PubMed ID: 8013277
[TBL] [Abstract][Full Text] [Related]
12. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.
Schumacher RJ; Gattermeir DJ; Peterson CA; Wisdom C; Day WW
Menopause; 2009; 16(1):177-83. PubMed ID: 18779758
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous absorption of [14C]methacrylamide in animals.
Hashimoto K; Tanii H
Arch Toxicol; 1985 Jun; 57(2):94-8. PubMed ID: 4026578
[TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing.
Järvinen A; Granander M; Nykänen S; Laine T; Geurts P; Viitanen A
Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():14-8. PubMed ID: 9389778
[TBL] [Abstract][Full Text] [Related]
15. Dermal absorption of chemicals: effect of application of chemicals as a solid, aqueous paste, suspension, or in volatile vehicle.
Hughes MF; Shrivastava SP; Sumler MR; Edwards BC; Goodwin JH; Shah PV; Fisher HL; Hall LL
J Toxicol Environ Health; 1992 Sep; 37(1):57-71. PubMed ID: 1522614
[TBL] [Abstract][Full Text] [Related]
16. The percutaneous absorption and excretion of promestriene (3-propoxy-17 beta-methoxy-1,3,5(10)-estratriene) in rats and humans.
Moore DH; Chasseaud LF; Darragh A; Taylor T; Cresswell DG
Steroids; 1983 Jan; 41(1):15-22. PubMed ID: 6658862
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous absorption of malathion in the guinea-pig: effect of repeated topical application.
Bucks DA; Marty JP; Maibach HI
Food Chem Toxicol; 1985 Oct; 23(10):919-22. PubMed ID: 4065766
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of 2-amino-4-nitrophenol in the rat.
Hofer H; Schwach GW; Fenzl C
Food Chem Toxicol; 1982 Dec; 20(6):921-3. PubMed ID: 6891676
[TBL] [Abstract][Full Text] [Related]
19. In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat.
Dupuis D; Rougier A; Roguet R; Lotte C; Kalopissis G
J Invest Dermatol; 1984 Apr; 82(4):353-6. PubMed ID: 6707487
[TBL] [Abstract][Full Text] [Related]
20. Topical bioavailability of a potential anti-acne agent (SC-23110) as determined by cumulative excretion and areas under plasma concentration time curves.
Wester RC; Noonan PK
J Invest Dermatol; 1978 Feb; 70(2):92-4. PubMed ID: 146056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
